thu
synthesi
glycan
resembl
human
glycan
structur
huge
complex
remain
major
challeng
glycoengin
plant
cell
challeng
due
complex
divers
glycan
differ
therapeut
recombin
protein
target
manipul
plant
nglycosyl
pathway
enabl
product
humanlik
oligosaccharid
enabl
gener
function
effect
biopharmaceut
recent
year
plant
reveal
simpl
nglycosyl
pathway
lack
oglycosyl
pathway
report
better
potenti
glycan
express
system
convent
one
plant
system
use
effect
express
system
complex
sialoglycan
nglycan
differ
strategi
use
express
complex
therapeut
sialyl
glycoform
plant
system
recent
differ
posttransl
modif
ptm
report
peptid
matur
activ
includ
proteolyt
process
tyrosin
sulfat
prolin
hydroxyl
hydroxyprolin
glycosyl
plant
glycan
epitop
human
complex
nglycan
often
target
lectin
import
cellcel
commun
role
plant
nglycan
find
import
protein
fold
biolog
function
includ
salt
stress
respons
cellulos
biosynthesi
microtubul
associ
biogenesi
sever
receptorlik
kinas
nglycosyl
major
posttransl
modif
ptm
eukaryot
import
maintain
cell
viabil
attach
core
nglycan
enabl
proper
protein
fold
secret
glycoprotein
membran
protein
endoplasm
reticulum
er
although
studi
nglycosyl
human
extens
knowledg
plant
restrict
due
limit
nlink
glycan
mutant
phenotyp
limit
method
modifi
target
nglycan
specif
site
limit
understand
protein
dynam
within
secretori
system
glycoprotein
move
er
golgi
apparatu
nglycan
moieti
undergo
matur
may
exit
er
via
altern
rout
vacuol
retain
highmannos
nglycan
structur
bypass
modif
golgi
eukaryot
nglycan
process
initi
er
precursor
convert
process
golgi
lead
format
complex
nglycan
fig
nglycan
process
ident
plant
mammal
till
format
vital
intermedi
gngn
mammal
gngn
oligosaccharid
enabl
diversif
nglycosyl
plant
gngn
structur
arrang
core
residu
although
mammal
core
fucosyl
occur
fucos
residu
plant
fig
plant
cell
extend
attach
form
lewisa
epitop
lea
plant
reveal
format
paucimannosid
structur
due
remov
termin
glcnac
residu
endogen
hexosaminidas
similar
insect
compar
human
complex
nglycan
nglycan
plant
system
lack
sialic
acid
contain
core
fuc
xyl
modif
may
contain
termin
lewisa
epitop
gal
link
termin
nacetylglucosamin
glcnac
fig
human
complex
nglycan
often
sialyl
contain
differ
epitop
includ
lewi
x
nacetyllactosamin
lacnac
n
lacdinac
although
plant
mammal
reveal
differ
nglycan
structur
share
high
degre
homolog
secretori
pathway
glycoengin
aim
product
recombin
glycoprotein
defin
glycosyl
profil
order
studi
impact
glycosyl
product
therapeut
agent
plant
express
system
design
gener
therapeut
import
glycoprotein
plant
system
find
import
biolog
safe
cost
effect
conveni
howev
plant
nglycosyl
pathway
differ
mani
aspect
compar
human
nglycosyl
modif
nglycosyl
pathway
plant
need
avoid
immunolog
challeng
get
human
authent
nglycosyl
molecul
plant
reveal
highli
conserv
secretori
pathway
fold
assembl
posttransl
modif
protein
similar
mammal
anim
sialyltransferas
st
consist
four
conserv
motif
name
larg
l
small
small
vs
motif
iii
although
sialic
acid
detect
plant
three
orthologu
contain
sequenc
similar
st
motif
identifi
arabidopsi
thaliana
l
gene
gene
id
code
golgi
resid
protein
lack
abil
transfer
sialic
acid
asialofetuin
oligosaccharid
acceptor
strategi
produc
human
therapeut
glycoprotein
plant
involv
retain
recombin
glycoprotein
er
nglycan
undergo
modif
ii
inhibit
plant
endogen
golgi
glycosyltransferas
iii
ad
new
glycosyltransferas
mammal
differ
approach
use
modifi
nglycosyl
pathway
differ
plant
speci
use
tdna
insert
mutant
rna
interfer
rnai
chemic
mutagenesi
target
nucleas
approach
n
benthamiana
find
import
molecular
farm
transient
express
protein
fast
yield
antibodi
differ
transient
express
system
includ
magnicon
system
peaq
vector
ptra
vector
zinc
finger
nucleas
zfn
transcript
activatorlik
effector
nucleas
talen
enabl
easi
knockout
multipl
gene
n
benthamiana
two
xylt
gene
two
five
fuct
gene
knock
talen
complet
elimin
activ
reduc
core
activ
crispr
system
use
knockout
two
four
gene
n
benthamiana
sia
polysial
acid
polysia
play
vital
role
biolog
function
therapeut
use
express
system
plant
design
multigen
vector
enabl
control
vivo
synthesi
sialyl
structur
human
sialyl
pathway
fig
sialyl
glycoprotein
transient
coexpress
human
lead
product
activ
function
polysia
structur
conserv
secretori
pathway
plant
mammal
enabl
product
igg
iga
effici
en
block
transfer
precursor
onto
grow
protein
subsequ
trim
er
cismedialgolgi
compart
reveal
similar
mammal
plant
synthesi
gngn
structur
fig
mammal
gngn
structur
undergo
intens
elong
modif
process
unlik
plant
add
xylos
innermost
mannos
residu
fucos
innermost
glcnac
residu
gngn
core
oligosaccharid
fig
absent
mammalian
cell
monoclon
antibodi
mab
plant
exhibit
nglycosyl
profil
singl
domin
oligosaccharid
structur
human
plant
pathway
thoroughli
investig
palacpac
et
al
bakker
et
al
overexpress
human
galt
tobacco
plant
elong
planttyp
lead
format
galactosyl
structur
drastic
reduc
degre
xylosyl
fucosyl
nut
product
mab
mab
suffer
challeng
format
unexpect
glycoform
incomplet
process
hybrid
structur
mutant
lack
plantspecif
core
achiev
elimin
endogen
enzym
xt
core
fig
knockdown
knockout
approach
respect
gene
gener
mutant
plant
line
thaliana
lemna
minor
n
benthamian
moss
physcomitrella
paten
dxtft
plant
n
benthamiana
glycosyl
mutant
lack
plantspecif
core
residu
gener
found
import
product
differ
mab
therapeut
schemat
diagram
fc
glycoengin
repres
fig
fcnglycosyl
profil
mab
achiev
elimin
core
lead
synthesi
humantyp
structur
contain
domin
gngn
detect
residu
reveal
unalt
antigen
bind
complementdepend
cytotox
cdc
activ
enhanc
antibodydepend
cellmedi
cytotox
adcc
effector
function
antibodi
also
enabl
gener
increas
galactosyl
sialyl
branch
bisect
glcnac
fucosyl
galt
target
late
golgi
compart
significantli
improv
dxtft
transgen
plant
mab
produc
glycoengin
plant
exhibit
singl
domin
fcnglycan
digalactosyl
aa
structur
predomin
serum
igg
mab
hiv
produc
glycoengin
plant
exhibit
improv
antivir
activ
glcnac
bound
innermost
mannos
residu
call
bisect
glcnac
report
enhanc
adcc
activ
mab
glycoengin
rituxan
herceptin
increas
bisect
structur
due
decreas
caus
block
fucosyltransferas
contrast
report
exist
cho
cell
overexpress
nacetylglucosaminyltransferas
iii
gntiii
done
hypothesi
increas
bisect
glcnac
produc
typic
hybrid
structur
instead
significantli
reduc
corefucos
content
dxtft
mutant
lack
plantspecif
core
modif
less
bisect
glycoform
synthes
compar
wild
type
plant
glycomodifi
dxtft
plant
produc
mammaliantyp
core
overexpress
core
gener
mab
without
fucos
ident
nglycosyl
plant
base
antibodi
batch
exhibit
glycosyl
profil
contain
predomin
nglycan
structur
gngn
digalactosyl
aa
structur
bind
similar
fccri
fccriia
fccriib
glycoform
lack
core
fucos
mediat
antivir
activ
variou
lentivirus
includ
complex
step
human
nglycosyl
termin
sialyl
difficult
accomplish
plant
lack
enzym
cascad
planta
sialyl
mab
recent
becom
possibl
introduct
enzym
mammalian
pathway
plant
allow
biosynthesi
sialic
acid
activ
transport
golgi
final
transfer
onto
termin
galactos
mab
coexpress
engin
human
sialyl
pathway
carri
sialyl
structur
six
mammalian
enzym
overexpress
plant
advanc
made
design
develop
plant
express
system
gener
recombin
nglycan
glycoprotein
glycoengin
nglycosyl
affect
mani
properti
recombin
glycoprotein
produc
planta
includ
effici
plantmad
antibodi
passiv
immun
shorter
halflif
blood
due
higher
clearanc
rate
remov
core
fucos
residu
mammalian
plant
nglycan
antibodi
report
increas
antibodydepend
cellular
cytotox
adcc
thu
prove
effect
biopharmaceut
food
drug
administr
fda
approv
first
plantmad
pharmaceut
protein
human
parenter
administr
includ
taligluceras
alfa
also
name
elelyso
produc
protalix
biotherapeut
applic
replac
therapi
gaucher
diseas
advantag
due
structur
expos
termin
mannos
residu
nglycan
structur
gener
plant
cell
vacuol
requir
effici
uptak
enzym
macrophag
n
benthamiana
extens
research
product
mucintyp
oglycan
nglycan
recombin
protein
plant
cell
lack
sialyl
glycan
import
biolog
function
anim
cell
transgen
human
produc
tobacco
suspensioncultur
cell
develop
two
gene
encod
human
cmpnacetylneuramin
acid
synthetas
cmpsialic
acid
transport
express
tobacco
suspensioncultur
cell
enabl
sialic
acid
biosynthesi
plant
act
bioreactor
mammalian
glycoprotein
product
human
butyrylcholinesteras
bche
tetramer
human
serum
sialyl
protein
find
therapeut
import
candid
bioscaveng
organophosphoru
nerv
agent
n
benthamiana
engin
express
sialyl
protein
transient
coexpress
bche
cdna
vector
lead
gener
rbche
express
monoand
disialyl
nglycan
intracellular
fluid
similar
human
protein
orthologu
iv
overexpress
recombin
engin
plant
enabl
gener
branch
nglycan
trisialyl
structur
better
effect
novel
therapeut
role
glycoprotein
hormon
erythropoietin
epo
find
import
mainten
hematopoiesi
provid
tissu
protect
recombin
human
epo
rhuepo
find
applic
treatment
anemia
howev
rhyepo
higher
dose
caus
harm
increas
rbc
mass
reveal
limit
role
tissu
protect
asialoerythropoietin
asialorhuepo
desialyl
form
rhuepo
report
lack
hematopoiet
activ
retain
cytoprotect
activ
chemic
enzymat
desialyl
rhuepo
suffer
cost
effect
although
plant
known
synthes
complex
nglycan
lack
enzym
transfer
sialic
acid
nglycan
chain
therefor
serv
potenti
express
gener
asialoerythropoietin
asialorhuepo
design
produc
plant
introduc
human
penultim
galactos
residu
regul
vivo
biolog
activ
coexpress
human
epo
gene
tobacco
plant
report
accumul
asialorhuepo
confirm
specif
erythrina
cristag
lectin
column
reveal
express
nglycan
structur
termin
residu
function
coexpress
galt
asialorhuepo
report
interact
epo
receptor
epor
similar
affin
rhuepo
desir
biolog
function
nglycan
termin
residu
import
biolog
activ
halfliv
recombin
therapeut
glycoprotein
human
fact
plant
express
neglig
amount
free
proteinbound
present
major
disadvantag
applic
biopharmaceut
express
system
thu
synthes
nglycan
plant
need
synthes
nucleotideactiv
deriv
cytidin
monophosphonacetylneuramin
acid
transgen
thaliana
plant
express
three
key
enzym
mammalian
biosynthesi
pathway
udpnacetylglucosamin
kinas
nacetylneuramin
acid
phosphat
synthas
cmpnacetylneuramin
acid
synthetas
design
develop
simultan
express
led
gener
signific
amount
planta
could
convert
cytidin
monophosphonacetylneuramin
acid
coexpress
cmpnacetylneuramin
acid
synthetas
lead
product
glycoprotein
plant
could
synthes
plant
cytosol
express
microbi
enzym
includ
lyas
escherichia
coli
synthas
campylobact
jejuni
two
model
plant
includ
bright
yellow
tobacco
cell
medicago
sativa
human
cmpnacetylneuramin
acid
neuac
synthas
hcss
hst
enabl
sialyl
nlink
glycan
mammalian
cell
hcss
synthes
cmpneuac
hst
use
donor
substrat
transfer
neuac
termin
posit
nlink
glycan
hcss
hst
gene
could
insert
express
suspensioncultur
tobacco
cell
enabl
sialyl
pathway
plant
produc
mammaliantyp
sialoglycoprotein
termin
neuac
residu
plant
two
engin
construct
contain
either
nativ
signal
peptid
human
lactoferrin
signal
peptid
sweet
potato
sporamin
fuse
human
lactoferrin
report
produc
ntermin
sequenc
rhlf
purifi
tobacco
ident
lf
human
milk
construct
natur
insert
n
benthamiana
rnadepend
rna
polymeras
gene
enabl
rapid
product
highvalu
hormon
enzym
antibodi
success
product
zmapp
cocktail
neutral
mab
two
chimer
antibodi
appli
ebola
outbreak
effici
product
vaccin
season
flu
intraven
immunoglobulin
therapeut
applic
zmapp
involv
direct
reaction
viru
bind
lock
key
lead
deactiv
provid
simul
immun
respons
ebolavir
protein
ebolaviru
gene
ebola
antibodi
need
drug
insert
agrobacterium
tobacco
plant
inject
infus
engin
viral
vectorencod
ebola
antibodi
plant
produc
antibodi
later
isol
form
drug
known
zmapp
fig
tabl
mammal
oglycan
secretori
protein
form
attach
nacetylgalactosamin
galnac
serin
threonin
residu
mucintyp
oglycosyl
modifi
addit
differ
monosaccharid
galactos
glcnac
sialic
acid
form
mucintyp
core
oglycan
structur
import
differ
biolog
process
fig
plant
unlik
mammal
prolin
residu
convert
hydroxyprolin
hyp
link
arabinos
residu
knockout
gene
could
elimin
oglycosyl
p
paten
therebi
help
modif
recombinantli
express
epo
overexpress
human
polypeptid
galnactransferas
arabidopsi
tobacco
cell
n
benthamiana
initi
ogalnac
format
differ
recombin
glycoprotein
includ
epo
antibodi
report
galnac
residu
act
substrat
subsequ
elong
overexpress
express
gene
human
sialyl
pathway
enabl
synthesi
sialyl
oglycan
parasit
helminth
secret
immunomodulatori
certain
nglycan
epitop
includ
lewi
x
ldnf
glycan
motiv
find
import
treatment
allergi
autoimmun
diseas
overexpress
glycosyltransferas
includ
fuct
galt
galnact
n
benthamiana
enabl
reconstruct
lewi
x
ldnf
motiv
find
import
develop
antihelminth
vaccin
detect
lowlevel
monosaccharid
glycoprotein
hydrolyz
accomplish
derivat
prior
highperform
liquid
chromatographi
hplc
fluoresc
liquid
chromatographi
lc
sonic
spray
ioniz
ssi
mass
spectrometri
ms
analys
lcssim
employ
identifi
composit
monosaccharid
includ
glucosamin
glucos
mannos
arabinos
xylos
sialic
acid
found
transgen
corn
plant
biomanufactur
human
protein
import
glycosyl
one
address
ptm
affect
protein
homogen
function
differ
engin
express
system
design
control
glycosyl
gener
engin
nand
olink
glycan
target
sugar
profil
variou
applic
gener
human
therapeut
despit
advanc
studi
nglycosyl
pathway
plant
studi
far
complet
complet
known
compar
human
nglycosyl
pathway
nglycosyl
pathway
complet
known
model
plant
organ
thaliana
differ
plant
speci
although
intragolgi
glycosyltransferas
report
thaliana
function
remain
unknown
assum
play
vital
role
synthesi
oglycosyl
protein
like
arabinogalactan
protein
studi
thaliana
rice
indic
nglycan
enabl
growth
stress
howev
complet
genom
sequenc
differ
plant
enabl
better
understand
nglycan
pathway
plant
effici
modif
research
excit
field
biolog
human
applic
gener
therapeut
compat
human
bodi
increas
across
globe
